Dashboard
Manage Tickers

ALNYALNYLAM PHARMACEUTICALS, INC.

Nasdaq alnylam.com


$ 247.80 $ 5.32 (2.19 %)    

Tuesday, 02-Jul-2024 15:59:40 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 486.92 $ 7.02 (1.46 %)
DIA $ 393.21 $ 2.37 (0.61 %)
SPY $ 548.87 $ 5.13 (0.94 %)
TLT $ 90.60 $ -0.07 (-0.08 %)
GLD $ 215.55 $ 0.28 (0.13 %)
$ 243.32
$ 242.49
$ 0.00 x 0
$ 258.00 x 100
$ 242.07 - $ 250.05
$ 141.98 - $ 252.87
1,491,693
na
30.69B
$ 0.68
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-15-2024 12-31-2023 10-K
3 11-02-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 10-27-2022 09-30-2022 10-Q
8 07-28-2022 06-30-2022 10-Q
9 04-28-2022 03-31-2022 10-Q
10 02-10-2022 12-31-2021 10-K
11 10-28-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-13-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-14-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-02-2018 06-30-2018 10-Q
25 05-04-2018 03-31-2018 10-Q
26 02-15-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-09-2017 06-30-2017 10-Q
29 05-05-2017 03-31-2017 10-Q
30 02-15-2017 12-31-2016 10-K
31 11-03-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 05-04-2016 03-31-2016 10-Q
34 02-12-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-13-2015 12-31-2014 10-K
39 11-06-2014 09-30-2014 10-Q
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

top-performing-industry-etfs-in-june-software-leads-returns-chipmakers-attract-most-inflows
Top Performing Industry ETFs In June: Soft...
07/01/2024 17:38:29

June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while ut...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
07/01/2024 17:35:22

cantor-fitzgerald-reiterates-neutral-on-alnylam-pharmaceuticals-maintains-150-price-target
Cantor Fitzgerald Reiterates Neutral on Al...
07/01/2024 12:50:36

Cantor Fitzgerald analyst Olivia Brayer reiterates Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Neutral and maintains $150 p...

rivian-automotive-and-carvana-were-among-the-10-biggest-large-cap-gainers-last-week-june-23-june-29-are-these-in-your-portfolio
Rivian Automotive And Carvana Were Among T...
06/30/2024 16:57:48

The top 10 large-cap stocks in the last week were RIVN, CUK, FDX, IOT, SUZ, CVNA, FTAI, RDDT, MDB, and ALNY. Many analysts have...

ubs-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-288
UBS Maintains Buy on Alnylam Pharmaceutica...
06/28/2024 14:06:17

UBS analyst Eliana Merle maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $253 to...

peering-into-alnylam-pharmaceuticalss-recent-short-interest
Peering Into Alnylam Pharmaceuticals's Rec...
06/27/2024 17:45:12

rbc-capital-maintains-outperform-on-alnylam-pharmaceuticals-raises-price-target-to-265
RBC Capital Maintains Outperform on Alnyla...
06/27/2024 14:04:25

RBC Capital analyst Luca Issi maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and raises the price target ...

stifel-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-295
Stifel Maintains Buy on Alnylam Pharmaceut...
06/27/2024 12:17:55

Stifel analyst Paul Matteis maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $215...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
06/26/2024 17:35:22

citigroup-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-291
Citigroup Maintains Buy on Alnylam Pharmac...
06/25/2024 18:41:08

Citigroup analyst David Lebovitz maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from...

b-of-a-securities-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-295
B of A Securities Maintains Buy on Alnylam...
06/25/2024 16:55:33

B of A Securities maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $248 to $295.

leerink-partners-maintains-market-perform-on-alnylam-pharmaceuticals-raises-price-target-to-159
Leerink Partners Maintains Market Perform ...
06/25/2024 15:53:59

Leerink Partners maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Market Perform and raises the price target from $138 ...

td-cowen-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-282
TD Cowen Maintains Buy on Alnylam Pharmace...
06/25/2024 15:39:34

TD Cowen analyst Ritu Baral maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $260...

evercore-isi-group-maintains-outperform-on-alnylam-pharmaceuticals-raises-price-target-to-260
Evercore ISI Group Maintains Outperform on...
06/25/2024 14:36:55

Evercore ISI Group analyst Liisa Bayko maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and raises the pric...

barclays-maintains-overweight-on-alnylam-pharmaceuticals-raises-price-target-to-291
Barclays Maintains Overweight on Alnylam P...
06/25/2024 14:35:34

Barclays analyst Gena Wang maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Overweight and raises the price target fro...

rbc-capital-maintains-outperform-on-alnylam-pharmaceuticals-raises-price-target-to-250
RBC Capital Maintains Outperform on Alnyla...
06/25/2024 14:13:44

RBC Capital analyst Luca Issi maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Outperform and raises the price target ...

wells-fargo-maintains-equal-weight-on-alnylam-pharmaceuticals-raises-price-target-to-207
Wells Fargo Maintains Equal-Weight on Alny...
06/25/2024 13:52:50

Wells Fargo analyst Tiago Fauth maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Equal-Weight and raises the price tar...

morgan-stanley-maintains-equal-weight-on-alnylam-pharmaceuticals-raises-price-target-to-250
Morgan Stanley Maintains Equal-Weight on A...
06/25/2024 09:29:34

Morgan Stanley analyst Michael Ulz maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Equal-Weight and raises the price ...

nvidia-affirm-holdings-carnival-corp-alnylam-pharmaceuticals-tesla-why-these-5-stocks-are-on-investors-radars-today
Nvidia, Affirm Holdings, Carnival Corp, Al...
06/25/2024 02:18:47

On Monday, major U.S. indices showed mixed performance. The Dow Jones Industrial Average closed up by nearly 0.7% at 39,411.21,

needham-maintains-buy-on-alnylam-pharmaceuticals-raises-price-target-to-275
Needham Maintains Buy on Alnylam Pharmaceu...
06/24/2024 18:33:45

Needham analyst Joseph Stringer maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)